Southern Med Law Notes Xarelto Bleeding Lawsuit Claims Now Include 2,128 Fillings By Patients Who Allegedly Suffered Internal Hemorrhaging, Including Brain Bleeds, Were Hospitalized for Transfusions, or Died Due to Xarelto Complications.
Xarelto bleeding lawsuit filings are continuing to mount in courts around the country, as Southern Med Law notes that more than 2,100 cases are now pending in state and federal Xarelto litigations. According to court documents, at least 1,698 Xarelto bleeding lawsuits have been filed in a federal multidistrict litigation underway in the U.S. District Court, Eastern District of Louisiana. (In Re: Xarelto Products Liability Litigation, No. 2592) An additional 430 Xarelto cases are pending in a mass tort proceeding located in Pennsylvania’s Philadelphia Court of Common Pleas. (In Re: Xarelto Litigation, Case ID 150102349)
All of the Xarelto lawsuits pending in these two litigations were filed on behalf of patients who allegedly suffered serious Xarelto bleeding, including brain bleeds and gastrointestinal hemorrhages. In many of these cases, plaintiffs say they were hospitalized for transfusions due to their Xarelto complications. Other lawsuits were filed on behalf of families who allegedly lost a loved one to a fatal episode of Xarelto bleeding.
“We are not surprised that Xarelto bleeding lawsuit filings now exceed more than 2,100 cases. This new-generation blood thinner has been the subject of aggressive marketing, which has resulted in millions of Xarelto prescriptions being written for patients in the U.S.,” says Southern Med Law. “Based on inquiries received by our Firm from alleged Xarelto victims, we certainly expect these litigations to grow even larger.”
Xarelto is a new-generation anticoagulant that was launched in the in the U.S. in 2011. Its approved indications include the prevention of strokes, deep vein thrombosis (DVT), pulmonary embolism (PE), and blood clots in patients who have undergone hip or knee replacement surgery. Xarelto is also approved to lessen the risk of strokes in people with atrial fibrillation, as well as the treatment of DVT and PE.
[fda.gov/downloads/Drugs/DrugSafety/UCM280333.pdf, FDA, December 2014]
Xarelto lawsuits all include similar allegations regarding the purported inadequacy of its label warnings regarding uncontrollable internal bleeding. Plaintiffs also dispute marketing claims that they say suggest Xarelto is a superior alternative to warfarin, an older blood thinner also known as Coumadin. Both Xarelto and warfarin can cause episodes of dangerous internal bleeding, but this complication can be reversed in warfarin users with the use of vitamin K. There is currently no approved antidote to remedy Xarelto bleeding.
As both an attorney and practicing physician, Southern Med Law’s Dr. François Blaudeau possesses a unique understanding of the medical and legal questions relating to Xarelto lawsuits. If you or a loved one experienced life-threatening internal bleeding or other complications allegedly associated with Xarelto, please contact the Firm as soon as possible to learn more about your legal rights. You can arrange for a free, no obligation Xarelto lawsuit review by calling Southern Med Law today, at 205-547-5525.
About Southern Med Law and Filing A Xarelto Bleeding Lawsuit: Throughout his career, Dr. Blaudeau has worked hard to develop a strong reputation in healthcare litigation. His first-hand knowledge of medicine has made the Southern Med Law team an aggressive and effective advocate for those who were harmed due to negligent pharmaceutical companies. If you or a loved one where harmed by Xarelto, please contact Southern Med Law today to learn more about your legal rights. Call today for a free, no obligation Xarelto lawsuit review by filling out our online form, or by calling the office directly at 205-547-5525.
Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Medical Negligence/MedicalDevice/Pharma/Qui Tam